Asia-Pacific

This summary report highlights key takeaways from the co-branded event – ‘Global Vaccine Research Collaborative: Building Consensus for Future Health Emergencies Prevention, Preparedness, and Response’ – held on June 3, 2023, in Hyderabad, India. Organized by the Department of Pharmaceuticals, Government of India, PATH, and CEPI, the event was aimed at building a consensus among various stakeholders engaged in vaccine research, regulation, development, and manufacturing in G20 member states and special invitee countries.

This year's annual report features our annual financial overview, a list of PATH's funders and supporters, and our accomplishments in 2022.

This fact sheet describes Chemistry, Manufacturing, and Controls (CMC) work at PATH. It covers what CMC is and why it's important, where we work, our capabilities, and how interested parties can reach out to us for collaboration opportunities.

Respiratory syncytial virus (RSV) is a major, under–recognized public health problem causing more severe respiratory infections and hospitalizations in infants and young children each year than any other pathogen. New immunization tools are achieving licensure that could help change that.The opportunity to address this pervasive virus has never been better. To raise awareness, PATH and the World Health Organization are developing an evolving toolkit of communication materials that public health stakeholders and advocates can use to share information about RSV disease, new prevention tools, and delivery considerations.To learn more about the toolkit, visit the web page.Editable files are available upon request. Please contact us.

Use these slide decks to share the evidence supporting a single-dose regimen of HPV vaccine. Visit the Single-Dose HPV Vaccine Evaluation Consortium page for additional resources.

PATH, The Hepatitis Fund, and the City of Geneva have teamed up on an innovative approach to combat hepatitis B, HIV, and syphilis in Vietnam.

This milestone marks a key step forward in protecting African meningitis belt countries from deadly and debilitating meningitis epidemics

This document provides the benchmarks self-assessments, examples and resources to implement PATH's four change strategies through our projects and proposals.

To advance HIV prevention and treatment, PATH studied the acceptability and usability of HIV self-testing (HIVST) in India. The results are promising.

With over 35 years of experience in diagnostics development, PATH provides technical support for end-to-end diagnostics development to ensure that quality-assured, fit-for-purpose diagnostics are available and affordable to people and communities in low-resource settings.